---
$id: https://graph.org.ai/products/commodity/51142532
$type: Product
source: UNSPSC
code: "51142532"
title: "Melevodopa"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Melevodopa

**UNSPSC Code**: 51142532
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a dopamine agonist with the molecular formula C10H13NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M30686U4X4, chemically known as l-tyrosine, 3-hydroxy-, methyl ester (9ci) but generally known as melevodopa, which bears US NIH Compound Identifier 23497. European Medicines Agency schedules Melevodopa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32447. The term MELEVODOPA is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 No. 1, 2001, List 45). World Health Organization schedules melevodopa in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule melevodopa under HS 29225000 and SITC 51467. As of Q4 2014, MELEVODOPA remains the US FDA Preferred Term for this commodity. Melevodopa bears US NLM identifiers UMLS ID C0064871 and NCI Concept Code C83927. SMILES: COC(=O)C(CC1=CC(=C(C=C1)O)O)N.

